Related Experiment Video
Updated: Apr 6, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophilia in Rheumatologic/Vascular Disorders.
Hiromichi Tamaki1, Soumya Chatterjee1, Carol A Langford2
1Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, 9500 Euclid Avenue, A50, Cleveland, OH 44195, USA.
Eosinophilia is a key sign in rare rheumatologic and vascular diseases. This review details five such conditions, aiding in understanding their diverse features and management.
Area of Science:
- Rheumatology
- Vascular Medicine
- Immunology
Background:
- Peripheral and tissue eosinophilia characterize several rare rheumatologic and vascular diseases.
- These conditions present with diverse clinical, histologic, and therapeutic profiles.
- Growing knowledge exists despite challenges posed by the rarity of these diseases.
Purpose of the Study:
- To compare and contrast five rheumatologic and vascular conditions associated with eosinophilia.
- To consolidate current understanding of these rare diseases.
Main Methods:
- Literature review and comparative analysis of five specific conditions.
- Focus on epidemiology, pathophysiology, clinical features, histology, treatment, and outcomes.
Main Results:
- Detailed comparison of eosinophilic granulomatosis with polyangiitis (Churg-Strauss), immunoglobulin G4-related disease, diffuse fasciitis with eosinophilia, eosinophilia-myalgia syndrome, and eosinophilic myositis.
- Highlights the spectrum of presentations and management strategies.
Conclusions:
- Understanding the distinct yet overlapping features of these eosinophilic disorders is crucial for accurate diagnosis and effective management.
- Further research is needed to elucidate the pathophysiology and optimize treatments for these rare conditions.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Endocarditis II: Clinical Features of Infective Endocarditis
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

